News archive

09 Nov 2004Actelion provides update on bosentan in Japan
07 Nov 2004Actelion stops acute heart failure study
26 Oct 2004Actelion announces 9-month results for 2004
18 Oct 2004New scientific studies show higher than expected prevalence of Pulmonary Arterial Hypertension in patients with Connective Tissue Diseases (CTD)
27 Jul 2004Actelion announces half-year results 2004
16 Jun 2004Extended license agreement for Zavesca
27 Apr 2004Actelion announces first quarter results 2004
02 Mar 2004Actelion / Merck Renin alliance achieves first milestone
02 Mar 2004Actelion announces Full Year 2003 financial results
25 Feb 2004Actelion honored with James D. Watson Helix 2004 Award
12 Feb 2004Actelion adopts US GAAP accounting standard for its financial reporting
15 Jan 2004Cerep to acquire Clinical Development Service Organization Hesperion
05 Jan 2004Zavesca® Capsules Available for Prescription in the US
15 Dec 2003Actelion reports further progress to additional markets for Tracleer® in Pulmonary Arterial Hypertension
04 Dec 2003Actelion and Merck form renin inhibitor alliance
28 Oct 2003Actelion announces 9-month results for 2003
30 Sep 2003Actelion acquires privately held Axovan AG:
17 Jun 2003Actelion Ltd and Axovan AG enter research collaboration
20 May 2003New analysis suggests treatment with Tracleer (bosentan) is associated with improved survival in primary pulmonary hypertension patients
29 Apr 2003Actelion announces first quarter results 2003; sustainable profitability ahead of schedule
Page:  1 2 3 4 5 6 7 8 9 10 11 12 13 14

Contact

Media Relations
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil
Switzerland
Phone:+41 61 565 62 62
Fax:+41 61 565 65 07
Contact us onlineHow to get to us

Top of pageSendbookmarkPrint page